Based upon national reviews of current policies, strategic plans, and actual programs, as well as key informant interviews conducted with staff of governmental departments, this study is a detailed analysis of in-country drug policies in relation to the prevention and treatment of HIV/AIDS. One of the first scientific reviews of disease policy, legislation, and financing, this comprehensive research study not only reviews HIV/AIDS policy but also provides recommendations for strengthening programs that deal with this disease.